Detectable reporter gene expression following transduction of adenovirus and adeno-associated virus serotype 2 vectors within full-thickness osteoarthritic and unaffected canine cartilage in vitro and unaffected guinea pig cartilage in vivo

Journal of Orthopaedic Research

Volumn 28, Issue 2, 2010, Pages 149-155

  Santangelo, Kelly S ^a   Baker, Sarah A ^a   Nuovo, Gerard ^b,c   Dyce, Jonathan ^a   Bartlett, Jeffrey S ^d   Bertone, Alicia L ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Adeno associated viral vector; Adenoviral vector; Cartilage; Osteoarthritis; RGD

Indexed keywords

ADENO ASSOCIATED VIRUS SEROTYPE2 VECTOR; ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID MODIFIED ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; SELF COMPLEMENTARY ADENO ASSOCIATED VIRUS SEROTYPE2 VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE GRAFT; CELL VIABILITY; CONTROLLED STUDY; DOG; EXPLANT; EXPOSURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GUINEA PIG; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION; SURFACE PROPERTY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CARTILAGE, ARTICULAR; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DOGS; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GUINEA PIGS; OSTEOARTHRITIS; TRANSDUCTION, GENETIC; TREATMENT OUTCOME;

EID: 73849122702     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20975     Document Type: Article

References (34)

1. Brooks PM. 2002. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol 14:573-577.
2. Lawrence RC, Helmick CG, Arnett FC, et al. 1998. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778-799.
3. Valdes AM, Hart DJ, Jones KA, et al. 2004. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 50:2497-2507.
4. Nixon AJ, Goodrich LR, Scimeca MS, et al. 2007. Gene therapy in musculoskeletal repair. Ann N Y Acad Sci 1117:310-327.
5. Khoury M, Jorgensen C, Apparailly F. 2007. RNAi in arthritis: prospects of a future antisense therapy in inflammation. Curr Opin Mol Ther 9:483-489.
6. Ghivizzani SC, Oligino TJ, Glorioso JC, et al. 2000. Gene therapy approaches for treating rheumatoid arthritis. Clin Orth Relat Res 379:S288-S299.
7. Ulrich-Vinther M. 2007. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orth Suppl 78:1-64.
8. Hunziker EB. 1992. Articular cartilage structure in humans and experimental animals. In: Kuettner KE, Schleyerback R, editors. Articular cartilage and osteoarthritis, 1st ed. New York: Raven Press, Ltd; p 183-199.
9. Gouze JN, Stoddart MJ, Gouze E, et al. 2004. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med 100:147-164.
10. Arai Y, Kubo T, Kobayashi K, et al. 1997. Adenovirus vectormediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. J Rheumatol 24:1787-1795.
11. Ishihara A, Zachos TA, Bartlett JS, et al. 2006. Evaluation of permissiveness and cytotoxic effects in equine chondrocytes, synovial cells, and stem cells in response to infection with adenovirus 5 vectors for gene delivery. Am J Vet Res 67:1145-1155.
12. Ikeda T, Kubo T, Arai Y, et al. 1998. Adenovirus vectormediated gene delivery to the joints of guinea pigs. J Rheumatol 25:1666-1673.
13. Arai Y, Kubo T, Fushiki S, et al. 2000. Gene delivery to human chondrocytes by an adeno-associated virus vector. J Rheumatol 27:979-982.
14. Kimura E, Maeda Y, Arima T, et al. 2001. Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA. Gene Ther 8:20-27.
15. Wickham TJ, Mathias P, Cheresh DA, et al. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell Online 73:309-319.
16. Kurtis MS, Schmidt TA, Bugbee WD, et al. 2003. Integrinmediated adhesion of human articular chondrocytes to cartilage. Arthritis Rheum 48:110-118.
17. Dmitriev I, Krasnykh V, Miller CR, et al. 1998. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a Coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72:9706-9713.
18. Kurachi S, Koizumi N, Sakurai F, et al. 2007. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon. Gene Ther 14:266-274.
19. Bakker AC, Van de Loo FAJ, Joosten LAB, et al. 2001. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis. Gene Ther 8:1785-1793.
20. Flotte TF. 2004. Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther 11:805-810.
21. Madry H, Cucchiarini M, Terwilliger EF, et al. 2003. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 14:393-402.
22. McCarty DM, Fu H, Monahan PE, et al. 2003. Adenoassociated virus terminal repeat (TR) mutant generates selfcomplementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10:2112-2118.
23. Wang Z, Ma H-I, Li J, et al. 2003. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 10:2105-2111.
24. Vanden Berg-Foels WS, Todhunter RJ, Schwager SJ, et al. 2006. Effect of early postnatal body weight on femoral head ossification onset and hip osteoarthritis in a canine model of developmental dysplasia of the hip. Pediatr Res 60:549-554.
25. Bendele AM, White SL, Hulman JF. 1989. Osteoarthrosis in guinea pigs: histopathologic and scanning electron microscopic features. Lab Anim Sci 39:115-121.
26. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-2232.
27. Wang CR, Shiau AL, Chen SY, et al. 2008. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer. Arthritis Rheum 58:1650-1656.
28. Haas CS, Amin MA, Ruth JH, et al. 2007. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum 56:2535-2548.
29. Darling EM, Hu JC, Athanasiou KA. 2004. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 23:425-432.
30. Smith KJ, Bertone AL, Weisbrode SE, et al. 2006. Gross, histologic, and gene expression characteristics of osteoarthritic articular cartilage of the metacarpal condyle of horses. Am J Vet Res 67:1299-1306.
31. Martin JA, Buckwalter JA. 2002. Human chondrocyte senescence and osteoarthritis. Biorheology 39:145-152.
32. Ulrich-Vinther M, Stengaard C, Schwarz EM, et al. 2005. Adeno-associated vector mediated gene transfer of transforming growth factor-beta1 to normal and osteoarthritic human chondrocytes stimulates cartilage anabolism. Eur Cell Mater 10:40-50.
33. Roach HI, Aigner T, Soder S, et al. 2007. Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Curr Drug Targets 8:271-282.
34. Simmons EJ, Bertone AL, Weisbrode SE. 1999. Instabilityinduced osteoarthritis in the metacarpophalangeal joint of horses. Am J Vet Res 60:7-13.